Thursday, December 20, 2012
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
IN VIVO: The Business & Medicine Report
Pages
Follow Us ...
| ||||||||
Headlines from 'The Pink Sheet' DAILY
Contributors
Labels
About This Blog
Welcome to The IN VIVO Blog, home of daily commentary on recent developments in biopharmaceutical business development, R&D, financing, marketing, and policy. Join us for discussion in the comments, or contact us via email.
Click These Links!
Blog Archive
-
▼
2012
(112)
-
▼
December
(24)
- REMINDER: Vote in Our Deals of the Year Poll!
- Deals Of The Week: 'Tis The Season To Be Jolly
- It's Time to Vote for IN VIVO Blog's Deals of the ...
- Alliance Deal of the Year Nominee: AZ/Amgen
- Financing Deal of the Year Nominee: Rusnano/Domain...
- M&A Deal of the Year Nominee Bristol-Myers/Amylin/AZ
- Financing Deal of the Year Nominee: bluebird bio
- M&A Deal of the Year Nominee: Amgen/Decode
- Deals Of The Week Sings Of An Icelandic Saga And T...
- Financings of the Fortnight Comes Bearing Gifts
- M&A Deals of the Year Nominee: Watson/Actavis
- Financing Deals of the Year Nominee: Foundation Me...
- Alliance Deal of the Year Nominee: Versant/Roche/I...
- Alliance Deal of the Year Nominee: Novartis/Univer...
- Alliance Deal of the Year Nominee: Transcelerate
- M&A Deal of the Year Nominee: Biogen/Stromedix
- Alliance Deal of the Year Nominee: Tolero/Mannkind
- Deals Of The Week: Has BioCryst Struck Out?
- Deals of the Year Exit/Financing Nominee: Warp Dri...
- Deals of the Year M&A Nominee: Pfizer/Nestle
- Deals of the Year Exit/Financing Nominee: Intarcia...
- Deals of the Year Alliance Nominee: Epizyme/Celgene
- Deals of the Year M&A Nominee: BMS/Inhibitex
- Deals of the Year Exit/Financing Nominee: Ovascience
-
▼
December
(24)
Footer
IN VIVO: The Business & Medicine Report
© Copyright 2014 Informa plc.
Informa Business Information. All Rights Reserved.
www.pharmamedtechbi.com
No comments:
Post a Comment